0001127602-21-009288.txt : 20210303
0001127602-21-009288.hdr.sgml : 20210303
20210303192334
ACCESSION NUMBER: 0001127602-21-009288
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210301
FILED AS OF DATE: 20210303
DATE AS OF CHANGE: 20210303
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: JONAS DANIEL
CENTRAL INDEX KEY: 0001238334
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39218
FILM NUMBER: 21711586
MAIL ADDRESS:
STREET 1: C/O CONMED CORP
STREET 2: 525 FRENCH ROAD
CITY: UTICA
STATE: NY
ZIP: 13502-5994
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: CONMED CORP
CENTRAL INDEX KEY: 0000816956
STANDARD INDUSTRIAL CLASSIFICATION: ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS [3845]
IRS NUMBER: 160977505
STATE OF INCORPORATION: NY
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 525 FRENCH ROAD
CITY: UTICA
STATE: NY
ZIP: 13502
BUSINESS PHONE: 315-624-3208
MAIL ADDRESS:
STREET 1: 525 FRENCH ROAD
CITY: UTICA
STATE: NY
ZIP: 13502
4
1
form4.xml
PRIMARY DOCUMENT
X0306
4
2021-03-01
0000816956
CONMED CORP
CNMD
0001238334
JONAS DANIEL
C/O CONMED CORP
11311 CONCEPT BOULEVARD
LARGO
FL
33773
1
EVP Legal Affairs,Gen. Counsel
Common Stock
2021-03-01
4
M
0
3221
39.87
A
16929
D
Common Stock
2021-03-01
4
S
0
3221
123.2596
D
13708
D
Common Stock
2021-03-01
4
M
0
624
41.93
A
14332
D
Common Stock
2021-03-01
4
S
0
624
123.2752
D
13708
D
Common Stock
2021-03-01
4
M
0
3500
41.93
A
17208
D
Common Stock
2021-03-01
4
F
0
2345
123.20
D
14863
D
Common Stock
2021-03-02
4
M
0
2199
39.87
A
17062
D
Common Stock
2021-03-02
4
S
0
2199
121.8437
D
14863
D
Common Stock
2021-03-02
4
M
0
1000
41.93
A
15863
D
Common Stock
2021-03-02
4
S
0
1000
121.9194
D
14863
D
Common Stock
2021-03-02
5
G
0
E
800
0
D
14063
D
Common Stock
2021-03-02
5
G
0
E
150
0
D
13913
D
Common Stock
2021-03-02
5
G
0
E
150
0
D
13763
D
Common Stock
2021-03-02
5
G
0
E
150
0
A
450
I
daughter
Options To Purchase Common Stock
39.87
2021-03-01
4
M
0
3221
0
D
2026-03-01
Common Stock
3221
2199
D
Options To Purchase Common Stock
41.93
2021-03-01
4
M
0
624
0
D
2027-03-01
Common Stock
624
24376
D
Options To Purchase Common Stock
41.93
2021-03-01
4
M
0
3500
0
D
2027-03-01
Common Stock
3500
20876
D
Options To Purchase Common Stock
122.55
2021-03-01
4
A
0
21250
0
A
2031-03-01
Common Stock
21250
21250
D
Options To Purchase Common Stock
39.87
2021-03-02
4
M
0
2199
0
D
2026-03-01
Common Stock
2199
0
D
Options To Purchase Common Stock
41.93
2021-03-02
4
M
0
1000
0
D
2027-03-01
Common Stock
1000
19876
D
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $123.25 to $123.49. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $123.25 to $123.405. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $121.80 to $122.22. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $121.80 to $122.33. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder.
The stock options were granted under the Company's 2015 Amended and Restated Long-Term Incentive Plan and generally vest in equal amounts over a five year period.
The stock options were granted under the Company's 2018 Long-Term Incentive Plan and generally vest in equal amounts over a five year period
Daniel S. Jonas
2021-03-03